World Orphan Drug Congress USA

August 26 - 27, 2021 | Washington, D.C.

Hosted by Terrapin Events

Jennifer Briggs Braswell, PhD, Executive Director of Foundation for Cell & Gene Medicine, will present "Educating the Public, Patients, and Families: how companies can more effectively communicate cell and gene therapies" in the afternoon of Thursday, August 26, 2021. She joins 1,200 rare disease professionals at the largest rare disease gathering globally.

On the 11th anniversary of World Orphan Drug Congress USA, they are building the most comprehensive program and inclusive gathering of rare disease stakeholders ever. Becoming the largest rare disease and orphan drug conference, globally, has allowed them to bring together leading industry, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The attendees rely on the World Orphan Drug Congress USA to meet, brainstorm and dialogue on ways to advance orphan drug development and improve access to life-saving therapies.

This event is principally for industry experts and other professional stakeholders. Patient Advocacy groups and individuals are also represented, as well as business and academic interests.